Product Information
TRANEXAMIC ACID 650 MG TABLET is a generic product labeled by Nordic Pharma, Inc., priced at $0.8344 per EA under NDC 69918030130. Its NADAC has been published 541 times since May 25, 2016.
FDA first approved this application on Nov 13, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
650 mg/1
Manufacturer
Nordic Pharma, Inc.NDC
69918030130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRANEXAMIC ACIDApproval Type
Authorized Generic (NDA)
FDA Application
NDA022430FDA Approved
11/13/2009
TE Code
AB
On Market Since
3/1/2016
Pharmacological Classes
Price Statistics
The NADAC for TRANEXAMIC ACID 650 MG TABLET has been published 541 times since May 25, 2016, and over the history we have for it it has declined 74.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8344 per EA |
|---|---|
| All-time high | $3.4937 (Sep 14, 2016) |
| All-time low | $0.8344 (Sep 23, 2026) |
| 52-week high | $1.0267 |
| 52-week low | $0.8344 |
| Median price | $1.9430 |
| Average price | $1.9086 |
| Largest weekly change | -36.1% (Nov 20, 2024) |
| Weeks tracked | 541 |
| Tracking since | May 25, 2016 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nordic Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tranexamic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antifibrinolytic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRANEXAMIC ACID 650 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRANEXAMIC ACID 650 MG TABLET, manufactured by Nordic Pharma, Inc., is $0.8344 per EA (NDC 69918030130), effective Sep 30, 2026.
How has the price of TRANEXAMIC ACID 650 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRANEXAMIC ACID 650 MG TABLET has declined 74.1%. It has been tracked across 541 weekly CMS publications since May 25, 2016.
What are the highest and lowest recorded NADAC prices for TRANEXAMIC ACID 650 MG TABLET?
Since May 25, 2016, the NADAC for TRANEXAMIC ACID 650 MG TABLET has ranged from a low of $0.8344 (Sep 23, 2026) to a high of $3.4937 (Sep 14, 2016), with a median of $1.9430 per EA.
Are there cheaper alternatives to TRANEXAMIC ACID 650 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRANEXAMIC ACID 650 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRANEXAMIC ACID 650 MG TABLET?
TRANEXAMIC ACID 650 MG TABLET (NDC 69918030130) is labeled by Nordic Pharma, Inc., and CMS classifies it as a generic product.